Therapeutic antibody drug monitoring using bioluminescent sensors proteins and a smartphone

Project Information

LUMABS

Grant agreement ID: 755471

DOI 10.3030/755471

Project closed

EC signature date 5 April 2017

Start date 1 June 2017

End date 30 November 2018

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 149 750,00

EU contribution € 149 750,00

Coordinated by

TECHNISCHE UNIVERSITEIT EINDHOVEN
Netherlands

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (3)

Paper-Based Antibody Detection Devices Using Bioluminescent BRET-Switching Sensor Proteins

Author(s): Keisuke Tenda, Benice van Gerven, Remco Arts, Yuki Hiruta, Maarten Merkx, Daniel Citterio
Published in: Angewandte Chemie International Edition, Issue 57/47, 2018, Page(s) 15369-15373, ISSN 1433-7851
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/anie.201808070

Dual-Color Bioluminescent Sensor Proteins for Therapeutic Drug Monitoring of Antitumor Antibodies

Author(s): Martijn van Rosmalen, Yan Ni, Daan F. M. Vervoort, Remco Arts, Susann K. J. Ludwig, Maarten Merkx
Published in: Analytical Chemistry, Issue 90/5, 2018, Page(s) 3592-3599, ISSN 0003-2700
Publisher: American Chemical Society
DOI: 10.1021/acs.analchem.8b00041

Ratiometric Bioluminescent Sensor Proteins Based on Intramolecular Split Luciferase Complementation

Author(s): Yan Ni, Remco Arts, Maarten Merkx
Published in: ACS Sensors, Issue 4/1, 2018, Page(s) 20-25, ISSN 2379-3694
Publisher: American Chemical Society (ACS)
DOI: 10.1021/acssensors.8b01381